NCT01748864View on ClinicalTrials.gov

Evaluation of the Biodistribution and Safety of 99mTC-Etarfolatide (EC20) in Normal Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions

Healthy

Interventions

DRUG

Etarfolatide (EC20)

Trial Locations (2)

Unknown

MD Clinical, Hallendale

Horizon Oncology, Lafayette

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Endocyte

INDUSTRY

NCT01748864 - Evaluation of the Biodistribution and Safety of 99mTC-Etarfolatide (EC20) in Normal Volunteers | Biotech Hunter | Biotech Hunter